Receptor activated Ca(2+) release is inhibited by boric acid in prostate cancer cells.
BACKGROUND:The global disparity in cancer incidence remains a major public health problem. We focused on prostate cancer since microscopic disease in men is common, but the incidence of clinical disease varies more than 100 fold worldwide. Ca(2+) signaling is a central regulator of cell proliferatio...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-06-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2698284?pdf=render |